Securing Europe’s medical supply chains against future shocks

Author (Person)
Series Title
Series Details Number 132
Publication Date June / July 2020
Content Type


The COVID-19 pandemic severely disrupted medical supply chains, leading some politicians to question Europe’s reliance on imports, particularly from China. To them, the solution is obvious: companies should be forced to make vital medical products in the EU rather than abroad. However, this is easier said than done, and pulling production into the EU does not necessarily leave the Union any less vulnerable to supply shocks. Being overly reliant on one location for vital products is a risk, whether the source is China or Europe.

Source Link
Alternative sources
Subject Categories
Subject Tags
Countries / Regions
International Organisations